Stay updated with breaking news from Lenzing Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-Ad-hoc: Lenzing AG / Key word: Dividend Lenzing AG: Lenzing AG suspends dividend policy for financial year 2023 08-March-2023 / 10:12 CET/CEST Disclosure of an inside information acc. to... | March 8, 2023
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Sodium Sulfate: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...
21st Austria weekly - Valneva Lenzing 14/02/2023 [pic1]Valneva: an Austrian/French specialty vaccine company announced that it completed enrollment and vaccination for a Phase 3 trial in adolescents VLA1553-321 of its single-shot chikungunya candidate VLA1553. First results the are expected mid-2023. The VLA1553-321 adolescent is also to support licensure Europe Brazil which would be first potential approval use endemic populations. Brazil had exponential increase cases 2021 comparison 2020 according data from Brazilian Vigilance Health Secretary
STOCKHOLM, SWEDEN / ACCESSWIRE / February 15, 2023 / Re:NewCell AB (publ) (FRA:6QP)(STO:RENEW) Renewcell 1 is up and running and the first customer deliveries have been made.October - December(Compared
EQS-News: Lenzing AG / Key word: Sustainability/Alliance Lenzing AG: Together with partners, Lenzing succeeds in reaching a milestone in the development of a circular-based fashion... | February 14, 2023